Tectonic Therapeutic Inc
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
TECX$21.89+6.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporation by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber | Description | Form | File No | Exhibit | Filing Date |
| 3.1* · Fourth Amended and Restated Certificate of Incorporation, as amended through June 20, 2024. | |||||
| 3.2 | Amended and Restated Bylaws, as currently in effect. | 8-K | 001-38537 | 3.2 | 6/25/2018 |
| 10.1 | Contingent Value Rights Agreement dated June 20, 2024, by and between Tectonic Therapeutic, Inc. and Computershare Trust Company, LLC. | 8-K | 001-38537 | 10.1 | 6/20/2024 |
| 10.2 | Form of Indemnification Agreement between Tectonic Therapeutic, Inc. and each of its directors and executive officers. | 8-K | 001-38537 | 10.2 | 6/20/2024 |
| 10.3# | 2019 Equity Incentive Plan of Tectonic Therapeutic, Inc., and form of award agreements thereunder. | S-4 | 333-277048 | 10.43 | 2/14/2024 |
| Incorporation by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber | Description | Form | File No | Exhibit | Filing Date |
| 10.4# | Tectonic Therapeutic, Inc. 2024 Equity Incentive Plan. | 8-K | 001-38537 | 10.6 | 6/20/2024 |
| 10.5# | Forms of Option Grant Notice, Option Agreement and Notice of Exercise under Tectonic Therapeutic, Inc. 2024 Equity Incentive Plan. | 8-K | 001-38537 | 10.7 | 6/20/2024 |
| 10.6# | Tectonic Therapeutic, Inc. 2024 Employee Stock Purchase Plan. | 8-K | 001-38537 | 10.8 | 6/20/2024 |
| 10.7# | Amended and Restated Employment Agreement, dated as of June 20, 2024, by and between Tectonic Therapeutic, Inc. and Alise Reicin, M.D. | 8-K | 001-38537 | 10.4 | 6/20/2024 |
| 10.8# | Form of Severance Plan and Form of Participation Agreement of Tectonic Therapeutic, Inc. | S-4 | 333-277048 | 10.47 | 4/15/2024 |
| 31.1* | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2* | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1*^ | Certification of Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 101.INS* | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document | ||||
| 101.SCH* | XBRL Taxonomy Extension Schema Document with Embedded Linkbase Documents | ||||
| 104* | Cover page formatted as Inline XBRL and contained in Exhibit 101 | ||||
| * | Filed herewith. |
|---|
| # | Indicates a management contract or any compensatory plan, contract or arrangement. |
|---|
| ^ | This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing by the registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.